Latest news
Loading news…
Horizon is a gene editing company that designs & engineers genetically-modified cells, applying them to advance human health.
Horizon Discovery was acquired by PerkinElmer in 2020 for $383M.
Total Funding
Available in Pro Last Funding
Available in Pro Acquisitions
4
Investments
1
Monthly Visits
Available in Pro Contacts
145
Patents
13
Company Details
Funding & Financials
Pro- Total funding
- Funding rounds
- Last funding
- Last funding type
- Last funding date
- Funding status
- Total equity funding
- Revenue range
Web Traffic
Pro- Monthly visits
- Global traffic rank
- 6-mo avg visits
- Visit duration (s)
- Pages / visit
- Bounce rate
- Rank change (mo)
Technology & IP
- Active technologies
- 22
- Active products
- 35
- Patents granted
- 13
- Trademarks
- 0
- Top patent class
- Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation Or Genetic Engineering
- IT spend
- $6M
Investor Activity
- Investments
- 1
- Portfolio orgs
- 1
Company Info
- Org types
- company, investor
- HQ
- Cambridge, Cambridgeshire, United Kingdom
Signals & Scores
- Trend (7d)
- -0.2
- Trend (30d)
- 0.1
- Trend (90d)
- 0
Investments by Horizon Discovery
Loading columns…
0 of 0Show
Page 1 / 1
Acquisitions by Horizon Discovery
Loading columns…
0 of 0Show
Page 1 / 1
Key People at Horizon Discovery
Head of Research Operations
Senior Scientist
Chief Financial Officer
Non-Executive Director
Corporate Innovation Partner
Chief Financial Officer
Founder
145
professional contacts at Horizon Discovery
Contact execs at Horizon Discovery →Explore 200,000+ acquisitions — free
Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.
Recent News related to Horizon Discovery
Loading news…
FAQs about Horizon Discovery
People who checked this page also checked these
Sectors Horizon Discovery invests & acquires in
Browse the full Acquirezy directory.